Neuroimaging studies reveal that APOE ε4 carriers, even in young adulthood, exhibit altered brain activity and reduced gray matter volume in regions vulnerable to AD, including the hippocampus, prefrontal cortex, and temporal–parietal cortices [68]. The gene discussed is APOE; the disease is Alzheimer disease.